SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-042734
Filing Date
2021-08-09
Accepted
2021-08-09 17:18:42
Documents
60
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q dsgn-10q_20210630.htm   iXBRL 10-Q 2696666
2 EX-31.1 dsgn-ex311_7.htm EX-31.1 20470
3 EX-32.1 dsgn-ex321_6.htm EX-32.1 11800
  Complete submission text file 0001564590-21-042734.txt   7810342

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA dsgn-20210630.xsd EX-101.SCH 51289
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dsgn-20210630_cal.xml EX-101.CAL 42820
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dsgn-20210630_def.xml EX-101.DEF 149330
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE dsgn-20210630_lab.xml EX-101.LAB 356810
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dsgn-20210630_pre.xml EX-101.PRE 273131
9 EXTRACTED XBRL INSTANCE DOCUMENT dsgn-10q_20210630_htm.xml XML 1305274
Mailing Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011
Business Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011 858-293-4900
Design Therapeutics, Inc. (Filer) CIK: 0001807120 (see all company filings)

IRS No.: 823929248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40288 | Film No.: 211157491
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences